{
    "nctId": "NCT03423849",
    "briefTitle": "The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy",
    "officialTitle": "Prospective Randomized Controlled Study of the Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Chemotherapy Effect, Disease-free Survival",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2, PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Disease-free survival (DFS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* All patients were required to give written informed consent.\n* Patients with distant metastasis who primary received anthracycline and taxane adjuvant chemotherapy after surgery.\n* After inorelbine and gemcitabine (NG) or vinorelbine and platinum (NP) regiments for 6 cycles,patients were assessed the effect of treatment. As for the patients with complete response (CR), partly response (PR) and stable disease(SD).\n* Have normal cardiac functions by echocardiography\n* ECOG scores are \u2264 0-1.\n* Patients are disposed to practice contraception during the whole trial.\n* The results of patients' blood tests are as follows:\n\nHb \u2265 90 g/L WBC \u2265 3.0\u00d7109/L Plt \u2265 100\u00d7109/L Neutrophils \u2265 1.5\u00d7109/L ALT and AST \u2264 2.5 times of normal upper limit. TBIL \u2264 1.5 times of normal upper limit. Creatinine \u2264 1.5 times of normal upper limit.\n\nExclusion Criteria:\n\n* Have other cancers at the same time or have the history of other cancers in recent five years, excluding the controlled skin basal cell carcinoma or skin squamous cell carcinoma or carcinoma in situ of cervix.\n* Active infections.\n* Severe non-cancerous diseases.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}